The supply of epidural kits has been impacted by a significant disruption in manufacturing, attributed to a major supplier halting production of epidural bags. This shortage is currently affecting various healthcare facilities across the country and is projected to continue until at least March. The government has identified the cessation of manufacturing by the key supplier as the primary cause of the ongoing supply gap, prompting healthcare providers to seek alternative sourcing and logistical adjustments to ensure continued patient care. This interruption in the epidural kit supply chain underscores vulnerabilities in medical inventory management and highlights the need for diversified sourcing strategies to mitigate similar risks in the future.